Evidence map›Paper›PMID 37542533›Full record

ArticleCurrent microbiology2023

First Report of a Wastewater Treatment-Adapted Enterococcus faecalis ST21 Harboring vanA Gene in Brazil.

Beatriz O Farias, Kaylanne S Montenegro, Ana Paula A Nascimento, Mariana Magaldi, Andressa S Gonçalves-Brito, Claudia Flores, Thais C Moreira, Felipe P G Neves, Kayo Bianco, Maysa M Clementino

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Deciphering vancomycin resistance inFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Beatriz O FariasInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Kaylanne S MontenegroEscola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Ana Paula A NascimentoInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Mariana MagaldiInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Andressa S Gonçalves-BritoInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Claudia FloresInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Thais C MoreiraInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Felipe P G NevesDepartamento de Microbiologia E Parasitologia, Instituto Biomédico, Universidade Federal Fluminense, Alameda Barros Terra, S/N. São Domingos, Niterói, RJ, 24020-150, Brazil.
Kayo BiancoInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil. kayo.bianco@fiocruz.br.ORCID http://orcid.org/0000-0002-7520-4097
Maysa M ClementinoInstituto Nacional de Controle de Qualidade Em Saúde, Fundação Oswaldo Cruz, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, Brazil.
Fundação Oswaldo Cruz · BREscola Nacional de Saúde Pública · BRBrazilian Network Information Center · BRUniversidade Federal Fluminense · BR

Funding

Fundação Oswaldo Cruz VPPCB-007-FIO-18-2-68
6 · The paper itself

Abstract

Enterococcus faecalis has emerged as an important opportunistic pathogen due to its increasing resistance to antimicrobials, mainly to vancomycin, which leads substantial cases of therapeutic failures. Wastewater treatment plants (WWTP), in turn, are considered hotpots in the spread of antimicrobial resistance according to One Health perspective. In this study, we present the first report of a vancomycin-resistant E. faecalis strain recovered from treated effluent in Brazil. For this purpose, the whole-genome sequencing (WGS) was carried out aiming to elucidate its molecular mechanisms of antimicrobial resistance and its phylogenetic relationships amongst strains from other sources and countries. According to Multilocus Sequence Typing (MLST) analysis this strain belongs to ST21. The WGS pointed the presence of vanA operon, multiple antibiotic resistance and virulence genes, and a significant pathogenic potential for humans. The phylogenomic analysis of E. faecalis 6805 was performed with ST21 representatives from the PubMLST database, including the E. faecalis IE81 strain from clinical sample in Brazil, which had its genome sequenced in this study. Our results demonstrated a strain showing resistance to vancomycin in treated effluent. To the best of our knowledge, this is an unprecedented report of vanA-carrying E. faecalis ST21. Furthermore, it is the first description of a vanA-harboring strain of this species from environmental sample in Brazil. Our data highlight the role of WWTP in the spread of AMR, since these environments are favorable for the selection of multidrug-resistant pathogens and the treated effluents, carrying antibiotic resistance genes, are directed to receiving water bodies.

Indexed as

Enterococcus faeciumGram-Positive Bacterial InfectionsAnti-Bacterial AgentsBrazilEnterococcus faecalisHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPhylogenyVancomycinVancomycin ResistanceAnti-Bacterial AgentsVancomycin

Identifiers

PMID37542533
OpenAlexW4385607744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.